Signaling Pathways Involved in the Development of Bronchopulmonary Dysplasia and Pulmonary Hypertension

Area of Science:

• Neonatal Medicine
• Pulmonary Biology
• Developmental Biology

Background:

• Premature infants face significant risks, including bronchopulmonary dysplasia (BPD), a major cause of mortality.
• BPD involves impaired alveolar and vascular development, exacerbated by neonatal stress (hypoxia, hyperoxia, ventilation injury).
• Pulmonary hypertension (PH) in BPD infants worsens prognosis, and current therapies to prevent BPD are lacking.

Purpose of the Study:

• To review signaling pathways implicated in the pathogenesis of BPD associated with PH.
• To explore potential management strategies based on understanding these pathways.

Main Methods:

• Review of existing literature on BPD pathogenesis.
• Analysis of animal experimental data on signaling factor deregulation in BPD.
• Synthesis of information on pathways including TGFβ, CTGF, FGF10, VEGF, caveolin-1, WNT/β-catenin, and elastin.

Main Results:

• Multiple signaling factors are deregulated in BPD pathogenesis.
• These pathways contribute to lung alveoli and vasculature damage.
• Specific pathways identified include TGFβ, CTGF, FGF10, VEGF, caveolin-1, WNT/β-catenin, and elastin.

Conclusions:

• Signaling pathway dysregulation is central to BPD and PH development.
• Targeting these pathways offers potential therapeutic avenues for BPD prevention and management.
• Further research into these pathways is crucial for improving outcomes in premature infants.